Quantum BioPharma Ltd. Announces At-the-Market Offering Agreement

Quantum BioPharma Ltd. has entered into an at-the-market (ATM) offering agreement with Rodman & Renshaw, LLC. This agreement allows the company to sell its Class B Subordinate Voting Shares over time through the ATM agreement. The press release and the ATM agreement, along with an opinion from Canadian counsel regarding the legality of the share issuance, are included as exhibits to the Form 6-K filing. The company has filed a registration statement on Form F-3 to facilitate these sales. The filing details the terms of the agreement, including the roles and responsibilities of both parties, the sales process, and the representations and warranties made by Quantum BioPharma Ltd.